Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$129.64 - $160.7 $72.8 Million - $90.3 Million
-561,670 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$119.87 - $145.67 $67.3 Million - $81.8 Million
561,670 New
561,670 $71.6 Million
Q3 2021

Nov 14, 2022

BUY
$128.64 - $184.79 $67 Million - $96.3 Million
520,898 New
520,898 $67.8 Million
Q3 2021

Nov 05, 2021

SELL
$128.64 - $184.79 $69.7 Million - $100 Million
-541,699 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$160.2 - $186.42 $86.8 Million - $101 Million
541,699 New
541,699 $96.2 Million
Q2 2021

Aug 10, 2021

SELL
$160.2 - $186.42 $88.9 Million - $103 Million
-554,976 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$150.19 - $173.5 $83.4 Million - $96.3 Million
554,976 New
554,976 $91.2 Million
Q1 2021

May 07, 2021

SELL
$150.19 - $173.5 $86.2 Million - $99.5 Million
-573,738 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$140.71 - $165.05 $80.7 Million - $94.7 Million
573,738 New
573,738 $94.7 Million
Q4 2020

Feb 10, 2021

SELL
$140.71 - $165.05 $86.2 Million - $101 Million
-612,399 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$105.46 - $144.13 $64.6 Million - $88.3 Million
612,399 New
612,399 $87.3 Million
Q3 2020

Nov 10, 2020

SELL
$105.46 - $144.13 $67.2 Million - $91.8 Million
-636,804 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$95.68 - $121.88 $60.9 Million - $77.6 Million
636,804 New
636,804 $70.3 Million
Q2 2020

Aug 07, 2020

SELL
$95.68 - $121.88 $64 Million - $81.6 Million
-669,115 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$87.74 - $152.74 $58.7 Million - $102 Million
669,115 New
669,115 $66.7 Million
Q1 2020

May 08, 2020

SELL
$87.74 - $152.74 $58.7 Million - $102 Million
-669,115 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$117.65 - $153.73 $78.7 Million - $103 Million
669,115 New
669,115 $99.9 Million
Q4 2019

Feb 12, 2020

SELL
$117.65 - $153.73 $78.7 Million - $103 Million
-669,115 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$125.18 - $143.24 $83.8 Million - $95.8 Million
669,115 New
669,115 $85.7 Million
Q3 2019

Nov 08, 2019

SELL
$125.18 - $143.24 $83.8 Million - $95.8 Million
-669,115 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$125.55 - $144.48 $84 Million - $96.7 Million
669,115 New
669,115 $95.4 Million
Q2 2019

Aug 09, 2019

SELL
$125.55 - $144.48 $84 Million - $96.7 Million
-669,115 Closed
0 $0
Q1 2019

May 11, 2020

BUY
$121.81 - $142.95 $628,174 - $737,193
5,157 Added 0.78%
669,115 $95.7 Million
Q4 2018

Mar 04, 2019

BUY
$115.94 - $166.74 $77 Million - $111 Million
663,958 New
663,958 $82.3 Million
Q4 2018

Feb 08, 2019

SELL
$115.94 - $166.74 $77 Million - $111 Million
-663,958 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$161.01 - $180.57 $107 Million - $120 Million
663,958 New
663,958 $112 Million
Q3 2018

Nov 09, 2018

SELL
$161.01 - $180.57 $91.5 Million - $103 Million
-568,258 Closed
0 $0
Q2 2018

Aug 12, 2019

BUY
$146.33 - $183.18 $83.2 Million - $104 Million
568,258 New
568,258 $97.9 Million
Q2 2018

Jul 23, 2018

SELL
$146.33 - $183.18 $87.4 Million - $109 Million
-597,144 Closed
0 $0
Q1 2018

May 15, 2019

BUY
$135.59 - $157.16 $81 Million - $93.8 Million
597,144 New
597,144 $90.2 Million
Q1 2018

May 09, 2018

SELL
$135.59 - $157.16 $64.8 Million - $75.1 Million
-478,083 Closed
0 $0
Q4 2017

Mar 05, 2018

BUY
$131.06 - $150.39 $62.7 Million - $71.9 Million
478,083 New
478,083 $64.4 Million
Q4 2017

Feb 09, 2018

SELL
$131.06 - $150.39 $60.6 Million - $69.5 Million
-462,158 Closed
0 $0
Q3 2017

Nov 13, 2018

BUY
$142.62 - $155.6 $65.9 Million - $71.9 Million
462,158 New
462,158 $67.6 Million
Q3 2017

Nov 07, 2017

SELL
$142.62 - $155.6 $83.8 Million - $91.4 Million
-587,343 Closed
0 $0
Q2 2017

Jul 24, 2018

SELL
N/A
-64,763 Reduced 9.93%
587,343 $91.3 Million
Q1 2017

May 11, 2018

BUY
N/A
116,328 Added 21.71%
652,106 $94.6 Million
Q3 2016

Nov 13, 2017

BUY
N/A
535,778
535,778 $0

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.